Who
Derica W. Rice
Director
Company insider
Files Form 4 as: Director, Bristol-Myers Squibb; Director, Walt Disney; Director, The Carlyle Group; Director, Target; EVP & President, CVS Caremark, CVS Health; EVP-Global Services and CFO, Eli Lilly and.
In numbers
- Trades disclosed
- 220
- Buys
- 0
- Sells
- 13
- Bought
- $0
- Sold
- $6.0M
- Companies
- 6
- Companies where not an officer
- 4
- First trade
- 21 Aug 2006
- Last trade
- 30 Sep 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 2 Oct 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $39K620.994 at $62.40 | filing |
| 30 Sep 2026filed 2 Oct 2026 | DIS Walt DisneyStreaming & media | SEC FORM 4 Code A | $121K1,152.3 at $104.88 | filing |
| 30 Jun 2026filed 2 Jul 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $39K672.51 at $57.62 | filing |
| 30 Jun 2026filed 2 Jul 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $39K672.51 at $57.62 | filing |
| 30 Jun 2026filed 2 Jul 2026 | DIS Walt DisneyStreaming & media | SEC FORM 4 Code A | $103K1,023 at $100.80 | filing |
| 30 Jun 2026filed 2 Jul 2026 | DIS Walt DisneyStreaming & media | SEC FORM 4 Code A | $103K1,023 at $100.80 | filing |
| 1 May 2026filed 1 May 2026 | CG The Carlyle GroupCapital Markets & Asset Management | SEC FORM 4 Code A | —4,450 at $0.00 | filing |
| 1 May 2026filed 1 May 2026 | CG The Carlyle GroupCapital Markets & Asset Management | SEC FORM 4 Code A | $145K2,933 at $49.44 | filing |
| 1 May 2026filed 1 May 2026 | CG The Carlyle GroupCapital Markets & Asset Management | SEC FORM 4 Code A | —4,450 at $0.00 | filing |
| 1 May 2026filed 1 May 2026 | CG The Carlyle GroupCapital Markets & Asset Management | SEC FORM 4 Code A | $145K2,933 at $49.44 | filing |
| 31 Mar 2026filed 2 Apr 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $39K638.912 at $60.65 | filing |
| 31 Mar 2026filed 2 Apr 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $39K638.91 at $60.65 | filing |
| 31 Mar 2026filed 2 Apr 2026 | DIS Walt DisneyStreaming & media | SEC FORM 4 Code A | $119K1,229.6 at $96.96 | filing |
| 31 Mar 2026filed 2 Apr 2026 | DIS Walt DisneyStreaming & media | SEC FORM 4 Code A | $119K1,229.6 at $96.96 | filing |
| 11 Mar 2026filed 13 Mar 2026 | TGT TargetMass, Grocery & Drug Retail | SEC FORM 4 Code A | —2,682 at $0.00 | filing |
| 11 Mar 2026filed 13 Mar 2026 | TGT TargetMass, Grocery & Drug Retail | SEC FORM 4 Code A | —2,682 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $220K3,996.367 at $55.05 | filing |
| 1 Feb 2026filed 3 Feb 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $220K3,996.37 at $55.05 | filing |
| 31 Dec 2025filed 5 Jan 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —695.217 at $0.00 | filing |
| 31 Dec 2025filed 5 Jan 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —695.22 at $0.00 | filing |
News
Can Eli Lilly's (LLY) Growth Machine Keep Delivering?LLY · insidermonkey.com · 18 Oct 2026NIH-Funded Study Finds GLP-1 Drugs Slow Aging In Mice, Boosting Outlook For Novo Nordisk (NYSE: NVO) And Eli Lilly (NYSE: LLY)LLY · foreignpolicyjournal.com · 18 Oct 2026A $1,000 Investment in Eli Lilly Became $18,637. The Obesity Boom Changed EverythingLLY · aol.com · 16 Oct 2026
0 headlines in the last 90 days name Derica W. Rice; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.